Loading…

Identification of Frataxin as a regulator of ferroptosis

Ferroptosis is a newly discovered form of non-apoptotic regulated cell death and is characterized by iron-dependent and lipid peroxidation. Due to the enhanced dependence on iron in cancer cells, induction of ferroptosis is becoming a promising therapeutic strategy. However, the precise underlying m...

Full description

Saved in:
Bibliographic Details
Published in:Redox biology 2020-05, Vol.32, p.101483-101483, Article 101483
Main Authors: Du, Jing, Zhou, Yi, Li, Yanchun, Xia, Jun, Chen, Yongjian, Chen, Sufeng, Wang, Xin, Sun, Weidong, Wang, Tongtong, Ren, Xueying, Wang, Xu, An, Yihan, Lu, Kang, Hu, Wanye, Huang, Siyuan, Li, Jianghui, Tong, Xiangmin, Wang, Ying
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ferroptosis is a newly discovered form of non-apoptotic regulated cell death and is characterized by iron-dependent and lipid peroxidation. Due to the enhanced dependence on iron in cancer cells, induction of ferroptosis is becoming a promising therapeutic strategy. However, the precise underlying molecular mechanism and regulation process of ferroptosis remains largely unknown. In the present study, we demonstrate that the protein Frataxin (FXN) is a key regulator of ferroptosis by modulating iron homeostasis and mitochondrial function. Suppression of FXN expression specifically repressed the proliferation, destroyed mitochondrial morphology, impeded Fe–S cluster assembly and activated iron starvation stress. Moreover, suppression of FXN expression significantly enhanced erastin-induced cell death through accelerating free iron accumulation, lipid peroxidation and resulted in dramatic mitochondria morphological damage including enhanced fragmentation and vanished cristae. In addition, this type of cell death was confirmed to be ferroptosis, since it could be pharmacologically restored by ferroptotic inhibitor Fer-1 or GSH, but not by inhibitors of apoptosis, necrosis. Vice versa, enforced expression of FXN blocked iron starvation response and erastin-induced ferroptosis. More importantly, pharmacological or genetic blocking the signal of iron starvation could completely restore the resistance to ferroptosis in FXN knockdown cells and xenograft graft in vivo. This paper suggests that FXN is a novel ferroptosis modulator, as well as a potential provided target to improve the antitumor activity based on ferroptosis. [Display omitted] •FXN suppression inhibited cell proliferation, decreased assembly of Fe–S clusters and exacerbated iron accumulation.•FXN is a key regulator of ferroptosis by modulating iron homeostasis and mitochondrial function.•Blocking the signal of iron starvation could restore the resistance to ferroptosis in FXN knockdown cells.
ISSN:2213-2317
2213-2317
DOI:10.1016/j.redox.2020.101483